The two genes that were under positive selection in most branches or nodes were EGFR and RYR3. EGFR encodes the epidermal growth factor receptor and has been largely implicated in the development of different types of cancers71,72, and has been explored as a treatment for neuropathic pain in cancer patients73. This evidence concerns the gene EGFR and cancer.